Global, regional, and national incidence and year lived with disability for benign prostatic hyperplasia from 1990 to 2019

XF Xu, GX Liu, YS Guo, HY Zhu… - American Journal of …, 2021 - journals.sagepub.com
… and focusing on the incidence and YLD, we reported the global, regional, national incidence
and YLD for BPH by age and SDI, measured the ASR trends of the incidence and YLD, …

Prevalence, incidence, and years lived with disability due to gout and its attributable risk factors for 195 countries and territories 1990–2017: a systematic analysis of …

S Safiri, AA Kolahi, M Cross… - Arthritis & …, 2020 - Wiley Online Library
… The number of literature studies, countries, and GBD world regions represented in the GBD
… 2017 for gout point prevalence (site-years = 507) and annual incidence (site-years = 105) …

Global, regional and national incidence, mortality and disability‐adjusted life‐years of skin cancers and trend analysis from 1990 to 2019: an analysis of the Global …

W Zhang, W Zeng, A Jiang, Z He, X Shen… - Cancer …, 2021 - Wiley Online Library
… generate cause-specific mortality and years of life lost (YLLs) estimates, and DisMod-MR
2.1 was used to estimate disease burden (incidence, and years lived with disability [YLDs]). All …

[HTML][HTML] Global low back pain prevalence and years lived with disability from 1990 to 2017: estimates from the Global Burden of Disease Study 2017

A Wu, L March, X Zheng, J Huang, X Wang… - Annals of …, 2020 - ncbi.nlm.nih.gov
… , epidemiological data to estimate the point prevalence and YLD outcomes. In GBD 2010,
DisMod-MR 1.0 was used to pool all data by world region. This was updated to DisMod-MR …

Global trends in the incidence, prevalence, and years lived with disability of Parkinson's disease in 204 countries/territories from 1990 to 2019

Z Ou, J Pan, S Tang, D Duan, D Yu, H Nong… - Frontiers in public …, 2021 - frontiersin.org
globally, and the age-standardized rate (ASR) of prevalenceYears lived with disability
(YLDs) is an index measuring the … of incident cases until rehabilitation or death, and the disability

Epidemiology of facial fractures: incidence, prevalence and years lived with disability estimates from the Global Burden of Disease 2017 study

R Lalloo, LR Lucchesi, C Bisignano… - Injury …, 2020 - injuryprevention.bmj.com
… The objective of this study was to estimate the global incidence, prevalence and years lived
with disability (YLDs) due to facial fractures and to estimate the leading injurious causes of …

Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis …

JM Kocarnik, K Compton, FE Dean, W Fu… - JAMA …, 2022 - jamanetwork.com
… The GBD 2019 estimation methods were used to describe cancer incidence, mortality, years
lived with disability, years of life lost, and disability-adjusted life years (DALYs) in 2019 and …

[HTML][HTML] Hearing loss prevalence and years lived with disability, 1990–2019: findings from the Global Burden of Disease Study 2019

LM Haile, K Kamenov, PS Briant, AU Orji, JD Steinmetz… - The Lancet, 2021 - thelancet.com
… older than 50 years. The Healthcare … national age-standardised rates of years lived with
disability, because countries with a low HAQ Index had higher rates of years lived with disability. …

Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study

GBD 2019 Ageing Collaborators - bmj, 2022 - bmj.com
years of life lived with disability.Finally, a microsimulation adjusted for years lived with disability
to … Globally all cause years lived with disability rates decreased for men but increased for …

Prevalence, deaths, and disability‐adjusted life years due to musculoskeletal disorders for 195 countries and territories 1990–2017

S Safiri, AA Kolahi, M Cross, C Hill… - Arthritis & …, 2021 - Wiley Online Library
… Weights Measurement Study and GBD 2010 Disabilityyears lived with disability (YLDs)
were calculated by multiplying the prevalence of each sequelae by sequelae-specific disability